BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,885,107 | -19.2% | 102,944 | -2.5% | 0.04% | -15.6% |
| Q2 2023 | $4,811,045 | +13.1% | 105,598 | +0.7% | 0.04% | +7.1% |
| Q1 2023 | $4,253,608 | +117533.0% | 104,872 | +47.8% | 0.04% | -23.6% |
| Q4 2022 | $3,616 | -99.9% | 70,935 | +0.5% | 0.06% | -9.8% |
| Q3 2022 | $3,801,000 | -11.0% | 70,567 | +6.1% | 0.06% | -10.3% |
| Q2 2022 | $4,272,000 | -15.2% | 66,509 | +2.4% | 0.07% | 0.0% |
| Q1 2022 | $5,036,000 | -14.9% | 64,944 | -5.8% | 0.07% | -6.8% |
| Q4 2021 | $5,920,000 | -4.7% | 68,960 | -10.7% | 0.07% | -3.9% |
| Q3 2021 | $6,212,000 | -7.6% | 77,229 | -7.6% | 0.08% | -2.6% |
| Q2 2021 | $6,725,000 | -5.5% | 83,538 | -1.0% | 0.08% | -11.4% |
| Q1 2021 | $7,114,000 | -1.6% | 84,344 | -6.4% | 0.09% | -3.3% |
| Q4 2020 | $7,227,000 | -3.3% | 90,064 | -3.1% | 0.09% | -9.9% |
| Q3 2020 | $7,477,000 | -3.1% | 92,973 | +3.7% | 0.10% | -17.9% |
| Q2 2020 | $7,720,000 | +2.5% | 89,664 | -3.4% | 0.12% | -10.9% |
| Q1 2020 | $7,534,000 | -0.3% | 92,790 | +2.7% | 0.14% | +20.0% |
| Q4 2019 | $7,554,000 | -9.2% | 90,341 | -5.0% | 0.12% | -12.9% |
| Q3 2019 | $8,319,000 | +11.0% | 95,103 | +3.9% | 0.13% | +13.8% |
| Q2 2019 | $7,494,000 | -0.6% | 91,499 | -1.3% | 0.12% | -3.3% |
| Q1 2019 | $7,540,000 | +15.1% | 92,731 | -6.8% | 0.12% | +3.4% |
| Q4 2018 | $6,552,000 | -23.8% | 99,541 | -10.8% | 0.12% | -2.5% |
| Q3 2018 | $8,599,000 | -3.1% | 111,541 | -7.2% | 0.12% | -1.7% |
| Q2 2018 | $8,877,000 | +6.3% | 120,219 | -6.4% | 0.12% | +9.0% |
| Q1 2018 | $8,351,000 | -5.6% | 128,396 | -6.2% | 0.11% | 0.0% |
| Q4 2017 | $8,846,000 | +1.5% | 136,846 | -1.5% | 0.11% | -0.9% |
| Q3 2017 | $8,717,000 | +5.1% | 138,920 | +1.4% | 0.11% | +2.8% |
| Q2 2017 | $8,297,000 | +12.7% | 137,047 | -3.5% | 0.11% | +13.5% |
| Q1 2017 | $7,365,000 | +13.3% | 142,023 | -3.2% | 0.10% | +10.3% |
| Q4 2016 | $6,502,000 | -9.4% | 146,644 | -2.7% | 0.09% | -9.4% |
| Q3 2016 | $7,176,000 | -10.9% | 150,749 | -15.3% | 0.10% | -10.3% |
| Q2 2016 | $8,051,000 | +4.3% | 178,042 | -5.3% | 0.11% | +9.2% |
| Q1 2016 | $7,721,000 | +5.0% | 187,953 | -2.5% | 0.10% | +7.7% |
| Q4 2015 | $7,353,000 | +15.1% | 192,740 | -0.9% | 0.09% | +11.0% |
| Q3 2015 | $6,390,000 | -53.9% | 194,535 | -1.8% | 0.08% | -48.8% |
| Q2 2015 | $13,857,000 | -0.4% | 198,149 | -2.5% | 0.16% | +3.9% |
| Q1 2015 | $13,914,000 | -7.9% | 203,129 | -1.4% | 0.15% | -7.2% |
| Q4 2014 | $15,104,000 | +0.0% | 206,091 | -2.0% | 0.17% | -2.4% |
| Q3 2014 | $15,099,000 | -7.7% | 210,377 | -7.0% | 0.17% | +0.6% |
| Q2 2014 | $16,355,000 | -6.8% | 226,208 | -5.1% | 0.17% | -6.6% |
| Q1 2014 | $17,539,000 | +0.4% | 238,364 | -5.1% | 0.18% | +4.6% |
| Q4 2013 | $17,477,000 | -1.5% | 251,285 | -6.9% | 0.17% | -4.9% |
| Q3 2013 | $17,740,000 | -7.9% | 270,053 | -2.9% | 0.18% | -9.5% |
| Q2 2013 | $19,263,000 | -8.1% | 278,086 | -3.7% | 0.20% | -7.8% |
| Q1 2013 | $20,968,000 | – | 288,650 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |